FERNANDO GALAVIZ: Open Payments
NPI 1003532847 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,139 in 53 payments from 16 companies in 2025. Trend: 2023 $718 · 2024 $1,342 · 2025 $1,139
Food & beverage: $1,139
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $213 |
| AstraZeneca Pharmaceuticals LP | 4 | $166 |
| ABBVIE INC. | 2 | $139 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $99 |
| Corcept Therapeutics | 4 | $98 |
| Exact Sciences Corporation | 4 | $76 |
| GlaxoSmithKline, LLC. | 4 | $66 |
| Aimmune Therapeutics, Inc. | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| PFIZER INC. | 2 | $40 |
Products named: CREON, FARXIGA, XIFAXAN, Korlym, OTEZLA, EVENITY, Cologuard Collection Kit, ZENPEP.
Industry payments across AZ — which companies pay providers there.
